TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from C-MER Eye Care Holdings Limited ( (HK:3309) ) is now available.
C-MER Medical Holdings Limited reported its annual results for the year ending December 31, 2024, showing a slight decline in revenue by 0.6% compared to the previous year. The company faced a significant drop in gross profit by 14.8% and reported a loss of HK$108,314,000 for the year, a stark contrast to the profit of HK$86,335,000 in 2023. The cessation of COVID-19 related medical consumables sales and significant non-cash impairments impacted the financial results. Despite these challenges, the adjusted profit for the year showed an increase of 11.9%, indicating some resilience in the company’s core operations.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited operates in the healthcare industry, focusing on providing core medical services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange under the stock code 3309.
YTD Price Performance: -13.93%
Average Trading Volume: 2,053,263
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$2.16B
See more data about 3309 stock on TipRanks’ Stock Analysis page.